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Copper, an essential metal, is a double-edged sword, as its vital nature is 
counterbalanced by the toxic effect that it can exert on cells when not properly controlled. 
As such, organisms have evolved defence mechanisms against copper toxicity and, in the 
yeast Saccharomyces cerevisiae, the transcription factor Ace1 orchestrates several of 
those mechanisms, by activating copper-detoxification genes. 
In Saccharomyces cerevisiae iron uptake is partially dependent on copper, as the 
membrane multicopper-oxidase Fet3, which is part of the high-affinity iron uptake 
system, requires copper as a cofactor. Aft1, the low iron-sensing transcription factor in 
yeast, is known to regulate the expression of FET3 gene. However, we found that a strain 
lacking FET3 is more sensitive to copper surplus conditions than a strain carrying the 
AFT1 gene disrupted. This finding suggests that under such conditions another regulator 
came into play and controls FET3 gene expression. 
We next evaluated whether Ace1 could be the alternative regulator of FET3 under 
copper excess. To test this hypothesis, the expression of FET3 gene in cells lacking ACE1, 
AFT1 or both was monitored, using yeast-one hybrid and qRT-PCR approaches. A 
decrease of FET3 transcripts is observed, under copper loading, when ACE1 is deleted, 
suggesting that Ace1 is involved in FET3 regulation. Remarkably, in the absence of AFT1 
we observed a copper-dependent induction of FET3 gene that was, however, completely 
abrogated when ACE1 was deleted from the aft1 mutant background. Our data clearly 
indicates that FET3 expression is dependent on Ace1 when copper is overly abundant. 
In this study, the link between iron and copper homeostasis was further 
established. Indeed, we found that ace1 cells display marked upregulation of Aft1’s 
targets, such as CTH2, and accumulate higher amounts of iron and copper, in a 
mechanism dependent on Aft1.  
Altogether, this work unveiled a novel protection mechanism against copper 
toxicity mediated by Ace1, which relies in the activations of FET3 and results in the 
restriction of Aft1 activity as to prevent excessive copper accumulation.  
Key-words: Saccharomyces cerevisiae, copper, Ace1, Fet3, copper-detoxification 
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O cobre é um metal essencial para a vasta maioria dos organismos, 
maioritariamente devido às suas propriedades de oxidação-redução, que o tornam ideal 
para ser cofactor de inúmeras proteínas. Nos humanos, o cobre é essencial para inúmeras 
funções celulares, nomeadamente para o metabolismo energético, produção de melanina 
e catecolaminas, destoxificação de espécies reactivas de oxigénio e homeostase de ferro. 
No entanto, a sua natureza essencial é contrabalançada pelos efeitos tóxicos causados 
quando este metal está presente em níveis acima dos considerados fisiológicos. De facto, 
sabe-se que o excesso de cobre potencia a produção de espécies reactivas de oxigénio 
(ROS), através da reacção de Fenton, e que este metal pode mesmo danificar os centros 
metálicos de enzimas e proteínas, levando à perda de função. Assim, os organismos 
desenvolveram inúmeros mecanismos de defesa contra a toxicidade provocada pelo 
cobre. Na levedura Saccharomyces cerevisiae, o factor de transcrição Ace1 é o 
responsável pela regulação destes mecanismos, ao activar genes de destoxificação do 
cobre, tais como genes codificantes de metalotioneínas CUP1 e CRS5, que actuam como 
quelantes de iões de cobre, e o gene SOD1, que codifica o superóxido dismutase, enzima 
que além de conter cobre no seu centro activo, é essencial na resposta ao stress oxidativo 
causado por este metal. 
Em Saccharomyces cerevisiae a entrada de ferro (Fe) na célula é parcialmente 
dependente do cobre, uma vez que o Fet3, uma ferroxidase de membrana que faz parte 
do complexo de transporte de alta afinidade de ferro, requer cobre como cofactor. O Aft1, 
o principal factor de transcrição envolvido na resposta à deficiência de ferro em levedura, 
é o conhecido regulador da expressão do gene FET3. No entanto, diversos resultados 
apresentados neste trabalho demonstram claramente que uma estirpe sem o gene FET3 é 
mais sensível ao excesso de cobre do que uma estirpe mutada no gene AFT1. Esta 
evidência sugere que, em condições de excesso de cobre, um outro regulador controla a 
expressão do gene FET3. Deste modo, foi avaliada a possibilidade de o factor de 
transcrição Ace1 ser o regulador alternativo do gene FET3 em condições de excesso de 
cobre. De facto, a região promotora do gene FET3 contém uma possível sequência de 
ligação do Ace1, localizada a -578 bp a montante do codão de iniciação ATG (+1). 
Através da monitorização dos níveis de expressão do FET3 na estirpe-selvagem e na 
estirpe mutada no gene ACE1 (mutante ace1), foi possível concluir que o factor de 
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transcrição Ace1 está envolvido na regulação do gene FET3. Foi ainda observado que 
mesmo na ausência do regulador Aft1, ocorre uma indução da expressão do FET3, 
dependente do cobre que, no entanto, é totalmente suprimida quando se elimina o gene 
ACE1.  
Através da monitorização da expressão de um dos genes alvo do factor de 
transcrição Aft1, CTH2, na estirpe selvagem e na estirpe ace1, em condições de excesso 
de cobre, através da técnica de qRT-PCR, observou-se que, na ausência do Ace1, há um 
aumento drástico dos níveis dos transcritos de CTH2. Estes dados sugerem que, na estirpe 
mutante ace1, a homeostase de ferro encontra-se desregulada, pelo que ocorrerá uma 
super-activação do factor Aft1. De acordo com esta hipótese, foi observado que a estirpe 
ace1 contém níveis de ferro e de cobre intracelulares marcadamente elevados quando 
comparados com os da estirpe-selvagem. Esta acumulação é dependente da actividade do 
regulador Aft1, uma vez que a sua eliminação (na estirpe mutante aft1ace1) repõe os 
níveis dos dois metais para valores semelhantes aos da estirpe-selvagem.  
O Fet3 é um enzima importante para a resposta celular ao excesso de cobre. Foi 
descrito que a estirpe mutante fet3 acumula grandes quantidades de cobre. Neste estudo, 
observou-se que esta acumulação ocorre através de um mecanismo dependente do factor 
de transcrição Aft1, dado que o duplo mutante fet3aft1 reverte os níveis de cobre 
intracelulares para níveis semelhantes aos da estirpe selvagem. Através da análise dos 
genes alvo do Aft1, foram seleccionados possíveis proteínas envolvidas neste mecanismo. 
A deleção do genes FET4, que codifica um transportador de ferro de baixa afinidade, que 
também tem a capacidade de transportar cobre, e do ARN4, que codifica um transportador 
de sideróforos de ferro, cujo substrato é a enterobactina, levou a um ganho de resistência 
ao cobre quando deletados de uma estirpe fet3. Resultados semelhantes foram registados 
após a deleção do gene FRE1, que codifica uma metaloreductase de membrana, envolvida 
no transporte de ferro e cobre. Estes resultados evidenciaram que a acção combinada de 
várias proteínas envolvidas no transporte de ferro contribuem para a acumulação de cobre 
observada numa estirpe mutante fet3. Assim a deficiência de ferro observada na estirpe 
mutante fet3, conduzirá à activação do factor de transcrição Aft1 que induzirá a expressão 
dos genes dessas proteínas, numa tentativa de colmatar a falta de ferro consequente da 
perda do sistema de transporte de ferro de alta afinidade.  
Neste estudo, foi ainda possível observar que a estirpe mutante aft1, que apresenta 
um fenótipo de sensibilidade em condições normais crescimento, recupera o seu défice 
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de crescimento quando cobre é adicionado ao meio de cultura. Contrariamente ao 
esperado, a atenuação observada não é devida a um aumento do conteúdo intracelular de 
ferro, quando as células são crescidas na presença de cobre, uma vez que os níveis de 
ferro da estirpe aft1 são inferiores aos níveis registados quando cultivada em condições 
normais de crescimento. Com o objectivo de compreender o mecanismo subjacente a este 
fenómeno, testaram-se outras vias dependentes de cobre poderiam estar afectadas em 
condições normais de crescimento no mutante aft1, nomeadamente a respiração 
mitocondrial, (dado que o cobre é um cofactor do citocromo c oxidase), e a resposta ao 
stress oxidativo (uma vez que o cobre faz parte do Cu,Zn-Superóxido dismutase). Através 
da análise da sensibilidade do mutante aft1 em meio YPDGE (meio de cultura rico, 
contendo quase exclusivamente fontes de carbono não fermentáveis), concluiu-se que a 
adição de cobre melhora a capacidade respiratória da estirpe aft1, dado que foi observado 
uma significativa recuperação da sensibilidade deste mutante. Além disso, a análise 
fenotípica do mutante aft1 cultivado em meio contendo paraquat (um composto gerador 
de anião superóxido), suplementado ou não com cobre, permite concluir que a adição de 
cobre alivia também a sensibilidade desta estirpe ao stress oxidativo provocado pelo 
paraquat. Assim, os resultados obtidos sugerem que numa estirpe aft1 a adição de cobre 
promove o metabolismo respiratório e fortalece a resposta ao stress oxidativo, 
contribuindo desta forma para o aliviar do défice de crescimento exibido por esta estirpe. 
Assim, no seu conjunto, os dados apresentados nesta dissertação permitem propor 
uma nova via de destoxificação de cobre mediada pelo factor de transcrição Ace1. Em 
condições de excesso de cobre, as células de levedura activam este regulador, que por sua 
vez irá induzir a expressão do gene FET3. Sendo uma proteína que contém cobre no seu 
centro activo, o enzima Fet3 contribui não só para o tamponamento dos iões de cobre 
livres presentes no citosol, como também para a entrada de ferro na célula. A entrada de 
ferro irá prevenir a activação excessiva do Aft1, e consequente expressão dos seus genes 
alvo, limitando assim a entrada de mais cobre através de transportadores de baixa 
afinidade para ferro, o que eventualmente, levaria à morte celular. Assim, neste estudo 
foi pela primeira vez demonstrado que além do seu papel essencial na destoxificação do 
cobre intracelular, o Ace1 possui também um papel fundamental na prevenção da entrada 
de cobre extracelular. 
Palavras-Chave: Saccharomyces cerevisiae, cobre, Ace1, Fet3, destoxificação de cobre 
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Copper is a transition metal that is present in nature predominantly in two 
oxidation states, Cu (I) and Cu (II). Given its ability to bind organic ligands and its 
electron transfer properties, this metal has a high potential to be utilized by organisms, 
mainly as a cofactor for proteins. In humans, copper is essential for oxidative 
phosphorylation, melanin and catecholamine production (through tyrosinase and 
dopamine-β-hydroxylase, respectively), superoxide dismutase activity and iron 
homeostasis [1].  
 
 
 
Wilson and Menkes diseases are rare genetic conditions caused by mutations in 
Cu-ATP-Binding-Cassette transporters, ATP7B and ATP7A, respectively [2, 3]. Within 
the cell, both proteins co-localize to the trans-Golgi network (TGN), where they import 
copper into TGN’s lumen, to be then incorporated in copper-containing proteins. 
However, both proteins appear to translocate to intracellular vesicles and to the plasma 
membrane in response to copper overload [4, 5]. These proteins have different 
localization patterns, with ATP7B being present mainly in the liver, and ATP7A 
distributed across the whole organism, with the exception of the liver. The phenotype of 
Wilson disease, due to a deficient biliary excretion of copper that causes an accumulation 
of copper in tissues, is a failure of liver function and neurological impairment. Menkes 
disease is characterized by systemic copper deficiency, as copper fails to reach 
circulation, which leads to the loss of activity of copper-containing proteins, and has as 
consequence a delay in neuronal development and a reduction of muscle tone [2, 3, 6]. 
There is now increasing evidence suggesting that neurodegenerative disorders, 
such as Alzheimer, Parkinson and Creutzfeldt-Jakob disease, are associated with an 
imbalance of copper homeostasis [7]. Copper is known to promote protein aggregation 
and oxidative stress, which are determinant factors for disease progression [7, 8]. 
Although copper levels above the homeostatic threshold have been observed in these and 
3 
 
other diseases, such as cancer, the mechanisms underlying this phenomenon are not yet 
clearly understood [7, 9] .  
Copper-chelation therapies are currently used to treat Wilson disease and are 
considered an attractive strategy to prevent the onset of neurodegenerative diseases [9].  
The treatment of Menkes disease relies on copper-supplementation therapy, 
through copper-histidine complex formulations, that can increase copper in ceruloplasmin 
and in organs, such as the liver [9–11]. 
 
 
 
In addition to their major role as protein cofactors, metals, such as Cu, Fe and Zn 
play active functions in infection biology. The use of copper as an antimicrobial 
compound dates from the early 19th century, when it begun to be incorporated in the 
Bourdeaux and Burgundy mixtures, the vineyard fungicides [12, 13]. In fact copper is 
now thought to have a protective role in infection, as Menkes disease carriers, that have 
systemic copper deficiency, are more susceptible to infections [10]. Also, mice fed on a 
low-copper diet have higher mortality rates upon infection with C. albicans [14]. 
  One of the host mechanisms to fight microbial pathogens is the withdrawal of 
essential metals, such as iron and calcium, from the pathogen’s vicinity, as to limit its 
growth [15, 16]. In contrast, upon infection, host copper-stores are mobilized, and innate 
immunity cells accumulate copper ions next to the pathogen in an attempt to increase the 
efficacy of pathogen killing (Figure 1.1) [17]. Macrophages constitute the first line of 
defence against microbial pathogens, such as fungi. These innate immunity cells have the 
ability to phagocyte the pathogen. In the phagolysosome environment, copper toxicity is 
maximized, as the low pH and the high concentrations of ROS potentiate copper-driven 
Fenton chemistry [13]. This was further corroborated by the observation that activated 
macrophages show marked upregulation of the copper-transporter, hCtr1, and of ATP7A 
at the phagolysosome membrane, which suggest that copper is being compartmentalized 
into the phagolysosome, after entering the macrophage (Figure 1.1) [18]. Interestingly, 
the macrophage-activating cytokine interferon-γ (IFN-γ) and lipopolysaccharide (LPS) 
also mediate the accumulation of copper inside the phagosome [18]. This regulated 
mechanism of copper compartmentalization ensures copper-damage only to the pathogen. 
Although accumulation of copper inside activated macrophages occur, the source of this 
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metal is unknown. Copper is thought to be mobilised from circulating ceruloplasmin, 
which contains over 90% of Cu in the plasma and, indeed, ceruloplasmin is increased 
during the acute phase of infection. However there are no direct evidences that 
ceruloplasmin is the copper-donor to activated macrophages [13, 19].  
 
  
Figure 1.1 – Copper role in pathogen killing by macrophages. Activated macrophages exploit copper toxic 
properties to promote pathogen killing by concentrating copper (Cu) inside the phagolysosome. 
Upregulation of copper transporters Ctr1 and ATP7A is observed upon infection 
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In 1996, the first complete sequence of a eukaryote genome, the Saccharomyces 
cerevisiae genome, was published [20, 21]. The yeast’s 12.8 Mb genome, composed of 
16 chromosomes, was revealed to contain more than 5.800 protein-coding genes, 85% of 
which are presently assigned to a biological function. Although twenty years have passed 
since the release of the genome, the baker’s yeast is still one of the most widely used 
eukaryotic model organism. This is due to the fact that it is genetically amenable, allowing 
genes to be deleted, altered or inserted in the genome, it has a short generation time and, 
importantly, it has many genes which are conserved among species, including plants, 
fungal pathogens and mammals [22]. A few years after the sequencing of S. cerevisiae 
genome, a library with almost each open-reading frame (ORF) mutated was generated 
[23]. The study of the effect of each deletion has allowed to uncover the biological 
function of many genes and to shed light on the molecular mechanisms of several human 
diseases [24–27]. 
Toxic metals (Cd, As, Hg, etc.) are major environmental and human health-
threatening hazards. On the other hand, essential metals (Zn, Fe and Cu), present in 
virtually all biological systems, are a double-edge sword, as its essential nature is 
counterbalanced by the toxic effect that it can exert on both eukaryotic and prokaryotic 
cells when not properly controlled (i.e., when scarce or in excess). To maintain adequate 
cellular metal levels and avoid metal-loading, cells have developed sophisticated systems 
to assure the balanced cellular metal homeostasis. The single celled yeast S. cerevisiae 
has proven to be an invaluable model organism to study metal homeostasis in higher 
eukaryotes, as a consequence of conservations across species of several of the key players 
involved in those processes [26].  
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In the budding yeast Saccharomyces cerevisiae copper is involved in three major 
biological processes: mitochondrial oxidative phosphorylation, superoxide anion 
detoxification and iron homeostasis [28, 29]. However, the same redox properties that 
make it ideal for electron transfer reactions also render it susceptible to generate reactive 
oxygen species (ROS), causing oxidative damage to cells [30]. 
To counteract sudden fluctuations in copper bioavailability, Saccharomyces 
cerevisiae cells have evolved mechanisms to maintain a tight control of copper 
homeostasis. These mechanisms are involved on the one hand in the upregulation of 
copper-uptake and mobilization systems, which enable copper to be utilized in crucial 
cellular processes, and on the other hand in the activation of copper detoxification 
systems, in order to prevent toxicity and repair Cu-induced damages [31–33]. 
 
 
When the intracellular copper content is low, yeast cells import copper mainly via 
the high affinity copper transport system, composed of two functionally redundant 
proteins: Ctr1 and Ctr3 [34] (Figure 1.2). Yeast cells deleted for CTR1 gene (ctr1 mutant 
strains) grow poorly in copper-depleted medium, have low Cu,Zn-SOD1 activity (and 
consequently higher oxidative stress), cannot grow in non-fermentable carbon sources 
and exhibit impaired high-affinity iron uptake [35]. CTR3 was identified during a screen 
for mutations allowing growth in low copper conditions, in the absence of CTR1 [34]. In 
most yeast laboratory strains, however, CTR3 gene is disrupted by a Ty2 transposable 
element and high-affinity copper transport is only conveyed by Ctr1 [36, 37]. The high-
affinity copper uptake system transports copper in the reduced, cuprous, state. As such, 
copper uptake is dependent on the activity of membrane metalloreductases, such as Fre1 
and Fre2, which reduce copper that, in the extracellular environment, is mainly in the 
oxidised, cupric, state (Figure 1.2) [38]. Fre1/2 are also involved in the reduction of 
extracellular iron prior to its uptake [39]. 
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Figure 1.2 - Key player in the yeast response to copper depletion. In low-copper conditions, Mac1, a copper-
responsive transcription factor, activates the expression of copper-uptake genes, such CTR1 and CTR3, but 
also of metalloreductases, as FRE1/2/7. Vacuole copper stores can also be mobilised, in this conditions, 
through Ctr2.In the cell, through the action of metallochaperones, copper can be incorporated in several 
enzymes, such as superoxide dismutase (SOD1), Fet3 and cytochrome c oxidase (CcO).  
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Besides the high-affinity transporters, copper can enter cells through low-affinity 
metal transporters, such as Fet4, Smf1 and Pho84 [40]. Fet4 is a cell surface low affinity 
iron transporter also involved in the uptake of other metals such as cobalt, cadmium, and 
copper [41]. Other transporters such as Smf1 and Pho84 are also thought to be able to 
transport copper to cells, however their significance is low, since Smf1, a manganese 
transporter, and Pho84, a phosphate transporter, are only active in manganese- and 
phosphate-starvation conditions, respectively [42, 43]. Furthermore, it was demonstrated 
that copper transported by Smf1 and Pho84 is not bioavailable, since ctr1ctr3fet4 mutants  
are defective in acquiring copper for SOD1 [44]. 
In the cytosol, free copper has to be minimized to avoid inadequate interactions 
that could lead to generation of reactive oxygen species (ROS). For this reason, under 
normal growth conditions, the yeast cell is thought to have less than one free copper atom, 
suggesting the existence of mechanisms that effectively bind and distribute intercellular 
copper [45]. This observation led to the discovery of a class of proteins, named 
metallochaperones, that bind and deliver copper to organelles and proteins [46]. In yeast 
several classes of metallochaperones have been identified. CCS (Cu Chaperone for 
SOD1) delivers copper to the Cu,Zn-SOD1 [47]. Cox17 binds and delivers copper to Sco1 
and Cox11, that promote the insertion of copper into the active sites of CcO, CuA and 
CuB, respectively [48]. Atx1 delivers copper to Ccc2 a Cu-P-type-ATPase, orthologue of 
the human proteins ATP7A and ATP7B [26, 49, 50], that pumps copper into the TGN’s 
lumen, where apoFet3 is loaded with copper [51, 52] 
In conditions of copper deficiency, yeast cells can also mobilize intracellular 
copper stores. Copper is predominantly stored in the vacuole through a mechanism yet to 
be investigated, as no vacuole copper importer has been identified so far. Copper 
mobilization from the vacuole is known to be mediated by Ctr2 [31].  
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Copper accumulation beyond homeostatic levels is highly toxic. Copper cycling 
between reduced and oxidised state allow it to undergo Fenton reactions, generating 
hydroxyl radical, an extremely labile molecule that reacts with biomolecules [30]. 
Additionally, metals, when in excess, can bind metal-sites in metalloproteins causing 
mismetallation, and consequently protein loss of function.   
In 2009, another possible mechanism of copper-mediated cellular toxicity was 
suggested by Imlay and Macomber [53]. Studies conducted in E.coli unravelled that 
copper is able to interfere with the [4Fe-4S] iron sulphur clusters present in dehydratases. 
Later, in 2014 Tan et al. [54] expanded this concept by showing that copper can also 
interact with [4Fe-4S]-assembly machinery, in particular with the bacterial proteins IscA 
and SufA. Isa1 and Isa2 are the yeast orthologues to the aforementioned bacterial proteins 
[55] and the interference of copper with the iron-sulphur assembly machinery was also 
observed in Saccharomyces cerevisiae [56].  
The response to copper-overload is mediated by Cu-chelator proteins, named 
metallothioneins, a class of small cysteine-rich proteins that have the ability to bind 
metals, thereby diminishing the toxic intracellular pool of free Cu(I)  ions [57]. In 
addition, superoxide dismutase (SOD1) plays a dual role in detoxifying copper: on the 
one hand it helps the cell dealing with copper-generated oxidative stress, and one the other 
hand, being a copper containing protein, it contributes to the decrease of cellular free 
copper [31, 58] (Figure 1.3). 
Excess of copper also triggers the post-translational regulation of the metal high-
affinity uptake system, by a mechanism involving Cu-binding to the C-terminal of Ctr1 
[59]. This interaction triggers degradation of Ctr1 at the plasma membrane [60]. Indeed 
a C-terminus truncated version of Ctr1 is functional in transporting copper but displays 
increased sensitivity to growth in Cu-enriched medium [59]  
To fight the toxic effects of copper accumulation, fungal pathogens, such as 
Candida albicans, besides the mechanisms above mentioned also use Cu-export pumps 
(Crp1, in C. albicans) to transport copper out of the cell [61, 62]. 
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Figure 1.3 - The yeast response to toxic levels of copper. When cells are exposed to copper surplus Ace1 
activates the expression of copper-detoxification genes that allow cells to cope with high copper levels. 
Metallothioneins, encoded by CUP1 and CRS5 genes, act as intracellular copper chelators and SOD1 
neutralises copper-generated ROS. 
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The transcriptional regulation of copper homeostasis is orchestrated by two 
copper-responsive transcription factors: Ace1 and Mac1 [39, 63]. 
When cells are subjected to copper-depletion, Mac1 activates the expression of 
genes involved in copper uptake, such as the high-affinity copper transporters, 
CTR1/CTR3 and the metalloreductases, encoded by FRE1, FRE2 and FRE7 genes [64] 
[39, 65]. Mac1 binds to two tandem TTTGCTCA sequences present in the promoter 
region of these genes [64]. When copper levels are adequate, Mac1 transcriptional activity 
is inhibited, by the binding of this metal to the copper regulatory domain of Mac1, causing 
its release from the DNA with consequent inhibition of gene expression [66]. 
Yeast cells exposed to high concentrations of copper (above 1 µM) activate Ace1, 
a transcription factor involved in the regulation of copper detoxification genes [32, 58]. 
When copper binds to Ace1, the protein undergoes a conformational change that allows 
it to bind the cis-element TTNNGCTG. Four Cu(I) ions bind to the cysteine-rich 
regulatory domain of this transcription factor [67]. Ace1 activates the expression of 
metallothioneins encoded by the CUP1 and CRS5 genes [58, 68]. The yeast genome 
contains 15 tandem copies of CUP1 [69] and Jensen et al. have demonstrated that Cup1 
plays the major role in copper detoxification, as cells harbouring a single copy of this 
gene are more effective in detoxifying copper than cells with one copy of CRS5 [33]. 
Interestingly, the tandem amplification of the CUP1 gene is related with an evolutionary 
gain of tolerance to copper [70]. In addition to copper-chelators, Ace1 also plays a role 
in activating the expression of the cytosolic Cu, Zn-SOD1, encoded by SOD1 [58]. 
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Several interconnections between iron and copper metabolism are known. In 
humans, copper is present in multicopper oxidases with ferroxidase activity, 
ceruloplasmin and hephaestin, two proteins essential for systemic iron homeostasis. 
Ceruloplasmin mobilises and oxidises iron prior to its association with transferrin, and 
hephaestin, mainly produced in enterocytes, transfers iron across the basolateral 
membrane into the circulation [71, 72].  
Also in the yeast Saccharomyces cerevisiae copper is necessary for the oxidase 
activity of Fet3, a membrane ferroxidase and the yeast ortholog of ceruloplasmin, that 
together with Ftr1 mediates the high-affinity uptake of Fe(III) [73]. The assembly of the 
Fet3-Ftr1 complex occurs in the TGN. Ccc2 a membrane P-type ATPase is responsible 
for the transport of copper into TGN’s lumen [26] Yeast mutant strains lacking Ccc2 have 
no functional Fet3, as without copper the apoFet3-Ftr1 maturation is impaired and the 
complex does not reach the plasma membrane [74]  
Interestingly, FET3 gene expression is induced by copper [63, 75]. Indeed, Fet3 
appears to have a protective role in copper-detoxification, since deletion of FET3 renders 
cells highly sensitive to copper excess [75, 76]. Li and Kaplan proposed that yeast cells 
lacking Fet3 try to re-establish iron homeostasis by upregulating low-affinity iron 
transporters, which transport iron but also copper, thereby leading to toxicity [77]. Later, 
Shi et al, demonstrated that Fet3 can use copper as a substrate, and proposed that the 
oxidation of Cu (I) to the less toxic species Cu(II), by Fet3 may constitute another line of 
protection mediated by this enzyme against copper toxicity [76]. 
In yeast, Aft1 is the major regulator of the transcriptional response to iron 
deficiency. Aft1 is constitutively expressed and in low-Fe conditions accumulates in the 
nucleus where it binds the DNA consensus sequence PyPyCACCC of its target genes 
[78]. When intracellular iron levels rise, Aft1 is inactivated by an ISC-intermediate, in a 
mechanism not yet fully understood, causing the nuclear export of this transcription factor 
[79]. In conditions of iron deficiency, Aft1 is the main regulator of FET3 gene expression 
[78] and Gross et al. suggested that under copper surplus conditions Aft1 also upregulates 
FET3 [63]. Moreover, the role Aft1 as a regulator of genes involved in copper 
homeostasis extends beyond FET3 regulation, as it also controls the expression of CCC2, 
CTR2  and FRE1 genes [80, 78].  
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In the yeast Saccharomyces cerevisiae, the multicopper oxidase Fet3 appears to 
have a pivotal role in the crosstalk between copper and iron homeostasis, as it is required 
to overcome both iron deficiency and copper overload. Accordingly, FET3 expression is 
induced in those conditions in a way dependent on Aft1 [63, 78]. At an initial stage of 
this work, however, while screening for metal-sensitive mutant strains, we found that the 
mutant fet3 is more sensitive to copper than the mutant aft1. This data indicates that a yet 
unidentified transcription factor is regulating FET3 expression under copper surplus 
conditions. In this context, the main aims of this study were to: 
1. Identify the transcription factor that regulates FET3 expression under copper 
excess growth conditions. 
2. Provide further insights into the interplay between iron and copper homeostasis. 
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Saccharomyces cerevisiae strains used in this study are listed on table 1. The 
deletion mutants constructed in this study were generated by the micro-homology PCR 
Strain Genotype Source 
By4742 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0 Euroscarf 
By4742 aft1 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YGL071W:: HIS Unpublished 
data 
By4742 fet3 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YMR058W::kanMX4 Euroscarf 
By4742 ace1 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YGL166W::kanMX4 This study 
By4742 arn4 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YOL158C::HIS This study  
BY4742 fet4 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YMR319C::HIS Unpublished 
data 
By4742 fre1 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YLR214W::HIS This study  
By4742 aft1fet3 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YGL071W:: HIS; 
YMR058W::kanMX4 
This study 
By4742 
aft1ace1 
MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0;  YGL071W::HIS 
YGL166W::kanMX4;  
This study 
By4742 fet3fet4 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YMR058W::kanMX4; 
YMR319C::HIS 
This study  
By4742 
fet3arn4 
MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0; YMR058W::kanMX4; 
YOL158C::HIS 
This study  
By4742 fet3fre1 MATα his3Δ1 leu2Δ0 lys2Δ0 uraΔ0;  YMR058W::kanMX4;  
YLR214W::HIS 
This study  
Fet3-TAPTag BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0;YMR058W-TAP::HIS Yeast Collection 
(Thermo 
Scientific-Open 
Biosystems) 
 
Fet3-TAPTag BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0; YMR058W-TAP::HIS 
YGL166W::kanMX4 
This study 
Table 1 - Strains used in this study 
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method [81], using primers listed in supplementary table S1. All the deletion mutants 
were confirmed by PCR analysis of genomic DNA using upstream and downstream 
specific primers, generally A1 and A4, which are listed in supplementary table S1. Strains 
were grown at 30°C in synthetic complete media (SC) (SC: 0.67% ammonium sulphate-
yeast nitrogen base without amino acids (Difco), 0.60% Bacto™ Casamino Acids 
(DIFCO) 2% D-glucose, supplemented with the appropriate amino acids, according to 
the strains auxotrophic markers) or SC lacking specific components (SD), to ensure 
plasmid retention or after transformation to select positive mutants. 
For long term storage, yeast strains were maintained at -80°C in 43.5% glycerol 
stock. For continued use strains were plated in YPD (0.3% (w/v) yeast extract, 1% 
peptone, 1% glucose/dextrose, 2% agar, dissolved in bi-distillated sterile water), grown 
for 2 days at 30ºC and stored at 4ºC.  
Phenotypic growth assays were carried out by growing cells overnight and 
inoculating them at 0.1 OD600/mL. Cells were grown until they reached early exponential 
phase (OD600 = 0.4-0.6). Five 10-fold serial dilutions were performed to obtain samples 
ranging from, approximately, 5x103 to 10 cells. 5 µL of each dilution were spotted in SC 
or YPD medium containing the concentrations of the mentioned drugs. Growth was 
recorded after up to 3 days at 30ºC. YPDGE was used to assay mitochondrial function, 
this medium contains almost exclusively non-fermentable carbon sources [82]. 
To perform the growth curves, 4 biological replicates of each strain were pre-
inoculated overnight in 3mL of SC media at 30ºC. Cells were inoculated at OD600=0.1 
with or without 2 mM of CuSO4. Optical densities at 600nm (OD600) were recorded for 
24hours.  
Escherichia coli strain XL1-Blue recA1 edA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F9proAB lacIqZDM15 Tn10 (Tetr)] (Stratagene) was used as the host for routine 
cloning purposes. Standard methods were used for genetic analysis, cloning and 
transformation. 
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To construct the pFET3-LacZ plasmid, FET3 promoter sequence was amplified 
by PCR with specific primers Fw_pFET3 and Rv_pFET3, which contain XbaI and KpnI 
restriction sites, respectively. The PCR product was digested with XbaI and KpnI. The 
resulting fragment was inserted into XbaI and KpnI digested yEP356R vector, which 
contains the lacZ reporter gene, using T4 DNA ligase (New England BioLabs). For 
successful ligations 15ng of vector were used and ideally 1µg of insert fragment. The 
ligation product was used to transform E. coli competent cells and transformants were 
selected by plating cells in in LB agar plates supplemented with Ampicillin 100µg/mL 
 
The procedure used for the competent yeast cells preparation was the one 
described by Gietz et al. [83], with few modifications.  
Cells were grown overnight in YPD, to reach stationary phase, and then inoculated 
at 0.2 OD600/mL, in 25mL YPD media. Cells were then grown 5 hours at 30ºC until 
OD600=0.7-0.8. The cell culture was centrifuged at 3600 rpm for 2 minutes, supernatant 
was discarded and the pellet was washed with bi-distillated sterile water and a similar 
centrifugation was performed. Cells were resuspended in 1 mL LiAc/TE solution (100 
mM Lithium acetate, TE 1X) and transferred to a 2 mL eppendorf. After centrifugation, 
cells were resuspended in 400 µL of LiAc/TE solution and stored at 4ºC for up to 5 days.  
 
Approximately, 1 µg of the disruption cassette DNA or 300 ng of plasmid DNA 
were mixed with 5 µg of carrier DNA (salmon sperm DNA [SIGMA]) and 300 µL of 
PEG3350 solution (40% PEG3350; 1X TE; 100 mM lithium acetate), and added to 50 µL 
of competent cells. The mixture was incubated for 30 minutes at 30ºC, 40µL of DMSO 
was added, followed by heat shock at 42ºC for 15 minutes. 800 µL of bi-distillated sterile 
water was added followed by centrifugation at 5000 rpm for 1 minute. Cells were 
resuspended in 1 mL of YPD, and incubated for 3 hours at 30ºC. Cells were then collected 
by centrifugation using the same conditions as above stated, resuspended in 200 µL of bi-
distillated sterile water and plated in appropriate selective media. 
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Western blot analyses were performed using early exponential phase cells (Fet3-
TAPTag and ace1 Fet3-TAPTag, challenged with the indicated concentrations of CuSO4 
and harvested at the indicated time points. Total protein extracts were obtained from 30 
mL of cell culture using Cell Lysis Buffer (50 mM HEPES , pH7.5; 100 mM KCl; 1mM 
EDTA;: 0.1% NP-40; 1 % glycerol) supplemented with 1mM PMSF and 1X protease 
inhibitors (ROCHE) and glass beads, as follows:  
After harvesting, cells were washed with 800 µL of cold bi-distillated sterile water 
and centrifuged at 14000 rpm for 1 minute. The supernatant was discarded and cells were 
re-washed with 800 µL Cell Lysis Buffer and centrifuged in the same conditions. Glass 
beads and 200 µL Cell Lysis Buffer were added to the remaining pellet and the mixture 
was vortexed for 15 minutes a 4ºC. After centrifugation at 14000 rpm for 30 minutes at 
4ºC, the supernatant (the protein extract) was collected to a new tube. The protein extracts 
were quantified using the Bradford method (BRADFORD BIORAD), and the absorbance 
was read at 595nm, in a SmartSpec™ 3000 spectrophotometer (BIORAD).  
Approximately, 100 µg of each protein sample was resolved by SDS-PAGE. The 
resolving 12% poly-acrylamide gel was prepared with 1.2mL acrylamide/Bis-Acrylamide 
(37.5:1), 1mL Tris-HCl 1.5 M pH8.8, 1.75 mL H2O, 20 µL SDS 20%, 40 µL APS 10%  
and 4µL TEMED. After polymerization of the resolving gel, the stacking 5% poly-
acrylamide gel was added (0.625 mL Acrylamide/Bis-acrylamide mix 40% (39:1); 0.63 
mL Tris-HCl 1M pH608, H2O 3.645 mL, 25 µL SDS 20%, 50 µL PSA 10% and 5 µL 
TEMED). Each sample was loaded into a lane along with a molecular-weight marker 
(Precision Plus Protein™ Standards: Dual Colour [BIORAD]). The electrophoresis was 
performed at 100 V in a BIORAD Mini-Protean® II with running buffer 1 X (STOCK 
10X: Tris 250 mM, glycine 2M and 1% (w/v) SDS), for 2hours or until the samples 
reached the bottom of the gel.  
After the run, the gel and the nitrocellulose membrane were readily placed in 
Transfer Buffer 1X for 10 minutes (20 mL Transfer Buffer Stock: 20mL methanol; 185µL 
SDS 20%; make up with bi-distillated water to a total of 100mL). The transfer system 
was assembled in the following way: 6 sheets of Hybond™ blotting paper (Amersham™) 
paper wet in buffer, nitrocellulose membrane (Amersham), SDS-page gel and 6 sheets of 
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Hybond™ blotting paper. The transfer to the membrane was performed during 50 minutes 
at 15 V in a in a semi-dry system (ATTA Trans-Blot SD Transfer Cell [BIORAD]). The 
success of the protein transfer to the nitrocellulose membrane was monitored by 
membrane incubation with Ponceau S solution (30% (w/v) Ponceau S and 30% (w/v) 
sulphosalicylic acid) diluted 1:10 in bi-distillated water. The membrane was washed and 
then incubated with 30mL of a solution of PBS 1X, Tween-20 0.1% with 5% low-fat 
milk, for 45 minutes at room temperature, to block unspecific interactions with the 
antibody. Protein levels were detected by incubation with the primary antibody for 1hour 
at room temperature and with the Horseradish peroxidase-conjugated secondary antibody 
in the same conditions. The antibodies used in this study are listed in Table 2. Between 
antibodies’ incubation and after the incubation with the secondary antibody, the 
membrane was washed 3 times during 10 minutes with PBS 1X Tween-20 0.1% solution. 
The detection system used was the chemo-luminescent SuperSignal® West Fento 
Maximum Sensitivity Substrate (Thermo). The membrane was then exposed to an 
autoradiograph film (Hyperfilm MP, Amersham). 3-PhosphoGlycerate Kinase (Pgk1) 
was used as loading control.  Western-blots were repeated at least twice with different 
protein extracts. 
 
Table 2 - Antibodies used in this study 
Protein Detected Primary Antibody Secondary Antibody 
Fet3-TAPTag 
Antibody Anti-TAP (Sigma) 
(Anti-TAPTag 1:5000 in PBS 1X 
Tween-20 0.1%) 
Horseradish peroxidase-
conjugated anti-Rabbit 
IgG (Santa Cruz 
Biotechnology) 
(Anti-rabbit IgG (1:5000) 
in PBS 1X Tween-20 
0.1%)  
Pgk1 
Antibody anti-3-phosphoglyceric 
Phosphokinase (Pgk1) (novex) 
(Anti-Pgk1 1:5000 in PBS 1X 
Tween-20 0.1%) (Life 
Technologies) 
Horseradish peroxidase-
conjugated anti-Mouse 
IgG (Santa Cruz 
Biotechnology (Anti-
mouse IgG (1:5000) in 
PBS 1X Tween-20 0.1%)) 
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The procedure used for the measurement of β-galactosidase activity was the one 
described by Möckli et al.[84], with few modifications.  
WT(BY4742) and ace1 strains were transformed with pFET3-LacZ plasmid. The 
transformed cells were grown in SD medium (without uracil) to early exponential phase 
(OD600 =0.5), and incubated with 0.5 mM of CuSO4 for 30 minutes. Cells were harvested 
by centrifugation resuspended in LacZ Buffer (10.6 mg/mL Na2HPO4.2H2O; 5.5 mg/mL 
NaH2PO4.H2O; 0.75mg/mL KCl and 0.25 mg/mL MgSO4.7H2O; pH 7, dissolved in H2O) 
supplemented with 270 µL β-mercaptoethanol per 100mL LacZ Buffer. Cells were 
permeabilized by adding 60µL of chloroform and vortexing for 45 seconds. 100 µl of 
ortho-Nitrophenyl-β-galactoside (ONPG) solution (4mg/mL dissolved in KPO4 Buffer 
0.1M (0.1M: 61mL K2HPO4 0.2M; 39 mL KH2PO4 0.2M) sterile water was added to cells 
and enzymatic activity was assayed by following the degradation of the colorimetric 
substrate ONPG at A420m, using the following equation:  
𝛽 − 𝐺𝑎𝑙𝑎𝑐𝑡𝑜𝑠𝑖𝑑𝑎𝑠𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =  
(𝐴𝑏𝑠420−(1.75×𝐴𝑏𝑠550))×1000
𝑡×𝑉×𝑂𝐷600
  
Where t stands for time in minutes and V for the total reaction volume. Enzyme 
activity was normalized against optical density (OD600). Absorbance measurements were 
performed in an Epoch BioTek® equipment 
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Triplicates of the indicated strains were grown in 3 mL of SC medium and 
cultured until reach stationary phase. Cells were then diluted to a final OD600= 0.1 in 40 
mL of SC and left untreated or treated with 2mM of CuSO4 for 15 hours. Cells were then 
collected by centrifugation at 4000 rpm for 5 minutes. The pellet was washed with 5 mL 
EDTA 10mM pH8, and twice with miliQ water (Q-POD® MiliQwater – Milipore). The 
pellet was resuspended with 5mL miliQ water and OD600 was measured. 4mL of the cell 
resuspensions were transferred to HS23204N tubes (Heathrow Scientific® LLC) and 
centrifuged at 4000g for 5 minutes. Supernatant was discarded and 1mL of Nitric Acid 
10% (v/v) was added to the cells. The samples were digested for 18h at 80ºC. Samples 
were centrifuged at 1200rpm for 5 minutes and 2mL of the supernatant were sent to 
analysis. Samples were analysed by inductively coupled plasma atomic emission 
spectroscopy (ICP-AES) at the service of Mass Spectrometry of REQUIMTE. Data 
obtained were normalized against OD600. 
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Biological triplicates of the indicated strains were grown until early exponential 
phase (OD600 = 0.4 -0.5), induced with 2mM of CuSO4 and harvested (30mL) at the 
indicated time points, by centrifugation at 3000 rpm for 2 minutes. Total cellular RNA 
content was extracted using the phenol-chloroform method. Cell were collected by 
centrifugation and the pellet was resuspended in 1 mL of cold sterile bi-distillated water, 
transferred to a microcentrifuge tube and again centrifuged in the same conditions, to 
remove the supernatant. 350 µL of Acidic phenol: chloroform (1:1) and 350 µL of LETS 
Buffer (LETS Buffer: 0.1 M LiCl; 0.01M Na2EDTA; 0.01M Tris-HCl pH 7.4; 0.2% SDS, 
dissolved in bi-distillated sterile water) was added to the samples. Samples were then 
vortexed 5 minutes at 4ºC, and centrifugation at 14000rpm to separate the organic from 
the aqueous fraction. The aqueous fraction was transferred to a microcentrifuge tube, 1 
mL of ethanol 100% was added and RNA was precipitated overnight at -20ºC. RNA was 
collected by centrifugation at 14000 rpm for 15 minutes and the pellet was resuspended 
in 200µL of ethanol 70% and centrifuged at 14000 rpm for 30 minutes. The pellet was 
air-dried and then resuspended in 100µL of RNAse free water and incubated 15 minutes 
at 65ºC to help the solubilisation of the pellet. RNA samples were treated with DNAse 
(TURBO DNAse [Ambion®]) according to manufacturer’s instructions, at 37ºC during 
40minutes. RNA samples were then purified using RNeasy® Mini Kit (QIAGEN). cDNA 
synthesis was performed using “Transcriptor Reverse Transcriptase” (ROCHE). qRT-
PCR reactions were prepared using the oligonucleotides described in table S1. Detection 
of the qRT-PCR products was done using the DNA intercalating compound SYBR Green 
(LightCycler LC-Faststart DNa MASTER SYBR Green I, (ROCHE)) and the qRT-PCR 
reaction was performed in a LightCycler® 480 equipment (ROCHE). Data was analysed 
with the software LightCycler® Software 4.1. Gene expression was normalized relatively 
to ACTIN mRNA levels. Two technical replicates were performed for each sample. 
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Gross et al. while identifying the copper regulon in Saccharomyces cerevisiae by DNA 
microarrays noticed that elevated copper levels also induced the expression of the high 
affinity iron uptake system composed of Fet3 and Ftr1 [63]. The authors further suggested 
that copper-induced expression of FET3 and FTR1 arose from an indirect copper effect 
on cellular iron pools and was mediated by Aft1 [63]. 
In this work we have examined the growth phenotype of wild-type, (WT) aft1 and 
fet3 strains in the presence of copper excess (Figure 3.1). Unexpectedly, we found that a 
strain lacking Fet3 is more sensitive to copper surplus conditions than a strain carrying 
the AFT1 gene disrupted (Figure 3.1). If Aft1 is the main regulator of FET3 expression 
under such conditions, one would expect that the aft1 mutant to be more sensitive than, 
or as sensitive as, the fet3 mutant. This finding suggests that FET3 has another yet 
unidentified regulator under copper loading conditions. Moreover, an epistatic analysis 
revealed that Fet3 cannot be downstream of Aft1 as the double mutant aft1fet3 has a more 
pronounced growth defect in copper surplus compared to fet3 and aft1 single mutants 
(Figure 3.1).  
Figure 3.1 - Under copper overload, Aft1 is not the major regulator of FET3 gene. A:Growth exhibited 
by the WT, aft1, fet3 and aft1fet3 strains in SC media was recorded over a period of 24 h. Closed 
symbols and open symbols represent strains grown in media containing or not 2mM of CuSO4, 
respectively. Each colour represents one of the used strains: WT is represented in black, aft1 in blue, 
fet3 in green and aft1fet3 in orange. 
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Aiming at understanding why the fet3 mutant is more sensitive to copper excess 
than the aft1 strain, we measured, by inductively coupled plasma atomic emission 
spectroscopy (ICP-AES), the intracellular copper and iron concentrations of both strains 
in copper overload conditions (Figure 3.2 A and B, respectively). We observed that cells 
lacking FET3 are iron depleted (Figure 3.2 B) and accumulate over 80% more copper 
than aft1 or wild-type cells (Figure 3.2 A), which is consistent with fet3 sensitivity to high 
copper. This finding has been reported by Li et al. [77], but here we show that fet3 
excessive accumulation of copper is mediated by Aft1. Indeed, deletion of this 
transcription factor from the fet3 background, avoids copper accumulation (Figure 3.2A). 
The activation of Aft1 in the fet3 mutant is probably due to the iron depletion observed 
in this strain, after copper treatment (Figure 3.2B).  
In an attempt to identify the players involved in the above mechanism, we search 
in the literature for Aft1 targets known to encode membrane proteins and previously 
associated with copper transport. We found FET4, FRE1 and ARN4 as promising 
candidates. Fet4 is a cell surface low affinity iron transporter able to transport other 
divalent metals, including copper [40, 85]. Fre1 is a membrane metalloreductases 
involved in the uptake of iron and copper  [64, 78]. Arn4 is a siderophore-iron transporter, 
whose substrate is enterobactin [86]. ARN4 expression increases in high copper and its 
deletion renders cells resistant to copper [87]. To assess the involvement of these proteins 
in copper accumulation of fet3 mutant, FET4, FRE1 and ARN4 genes were deleted from 
the fet3 background, and phenotypic growth assays were performed under copper loading 
conditions (Figure 3.2C). Deletion of each of the gene increase the resistance to copper 
compared with fet3, with the effect of FRE1 being the most pronounced (Figure 3.2C). 
None of the deletions, however, was able to fully restore cells growth in high copper. 
Interestingly we observed that supplementation of the growth medium with zinc or iron 
attenuates fet3 sensitivity to copper (Figure 3.2 D and E, respectively), which is consistent 
with the involvement of low-affinity metal transporters in this phenomenon.  
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Figure 3.2 - fet3 copper accumulation is dependent on Aft1. A: Copper (Cu) content of WT, aft1, fet3 and 
aft1fet3 strains were determined by ICP-AES, in SC medium after treatment with 2mM CuSO4 for 15 h. 
B: Iron (Fe) content of WT, aft1, fet3 and aft1fet3 strains were determined by ICP-AES, in SC medium 
after treatment with 2mM CuSO4 for 15 h. C: Growth sensitivity of WT, fet3, fe4, arn4, fre1, fet3fet4, 
fet3arn4 and fet3fre1 strains in SC plates and SC plates containing 3 or 5mM CuSO4  D: Growth sensitivity 
of WT and  fet3, in SC plates and SC plates containing 2mM of CuSO4 supplemented or not with 250µM 
ZnSO4. E: Growth sensitivity of WT and fet3, in SC plates and SC plates containing 2mM of CuSO4 
supplemented or not with 500µM FeSO4. 
. 
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Because the transcriptional response to copper overload is dependent on Ace1 [32, 
58], we put forward the hypothesis that Ace1 could play as well a role in regulating the 
expression of FET3. To test this, we first analysed FET3 promoter sequence using the 
online tool YEASTRACT [88] and found a putative Ace1 binding-site located at -578 bp 
from the ATG (+1) (Figure 3.3A). Next, a plasmid including the promoter region of FET3 
fused to the lacZ reporter gene (pFET3-lacZ) was generated and used to transform the 
WT and ace1 mutant strains. We observed that β-Galactosidase activity was higher in the 
WT compared to the mutant strain (Figure 3.3B). The dependence of FET3 on Ace1 was 
confirmed by the analysis of the levels of FET3 transcripts in both strains, either in the 
absence or presence of copper, by qRT-PCR (Figure 3.3C). Under non-stressed 
conditions (time point 0) both strains exhibit similar levels of FET3 mRNA, which is in 
agreement with the hypothesis that Ace1 only regulates FET3 under copper overload. To 
further demonstrate an Aft1-idependent role of Ace1 in FET3 regulation, AFT1 was 
deleted from the ace1 background and FET3 mRNA levels were followed by qRT-PCR. 
As depicted in Figure 3.3D, in the absence of Aft1, it was possible to observe a marked 
induction of FET3 expression that was, however, completely abrogated upon deletion of 
ACE1. 
Finally, we have also assessed the protein expression of a TAP-tagged version of Fet3 
driven by its native promoter. To this end, the ACE1 gene was deleted from a strain with 
a TAP-tagged genomic version of FET3 (WT) and Fet3 expression was monitored by 
Western blot using an anti-TAPtag antibody. In agreement with the gene expression data, 
we observed that protein levels were consistently higher in the WT compared to the ace1 
mutant strain (Figure 3.3 E). 
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Figure 3.3 - Ace1 regulates FET3 expression under copper excess conditions. A:  Schematic representation 
of the FET3 promoter region containing the one putative Ace1-binding site located at -578 upstream of the 
ATG. B: WT and ace1 mutant strains were transformed with the pFET3-lacZ plasmid. Cells were grown 
exponentially in SD medium and challenged with 0.5mM CuSO4 for 30 min. β-Galactosidase activity was 
assayed as detailed in Materials and Methods. C: WT (wild-type) and ace1 strains were challenged with 
2mM CuSO4 and harvested at the indicated time points. The expression of FET3 was monitored by qRT-
PCR. D: aft1 and aft1ace1 strains were challenged with 2mM CuSO4 and harvested at the indicated time 
points. The expression of FET3 was monitored by qRT-PCR. E: The WT Fet3-TAP and the ace1 Fet3-
TAP strains were incubated with 2 mM CuSO4 or the indicated times. Fet3 protein levels were analysed by 
Western-blot with an anti-TAP antibody. Fet3 protein levels were normalized to Pgk1. Significance of 
differences was calculated with the t-test (* p<0.05). 
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In this work we show that in the absence of FET3 cells accumulate high amounts of 
copper in an Aft1 dependent manner (Figure 3.2A), which is deleterious to the cell. We 
suggest that iron depletion caused by deletion of FET3 leads to the activation of Aft1 that 
in turn activates genes involved in low-affinity metal uptake. In this context it is 
reasonable to hypothesize that Ace1 activation of FET3 under copper loading serves to 
prevent cells from sensing iron depletion, which would activate Aft1 and, consequently, 
low-affinity iron transporter that would transport copper to the cell. 
As a first approach to test this hypothesis, Aft1 activity in WT and ace1 strains was 
monitored by evaluating the expression of CTH2, a target gene of Aft1 [89], by qRT-PCR 
(Figure 3.4 A). After copper treatment, the expression of this gene is upregulated in both 
strains, but a highly pronounced increased in CTH2 mRNA levels (about 9-fold) was 
observed in ace1 cells 60 minutes after copper exposure, suggesting that Aft1 is more 
active in this strain (Figure 3.4A). In this sense, the unexpected increase of FET3 mRNA 
levels in ace1 cells observed after 60 minutes of induction with copper (Figure 3.2 C) 
may also be mediated by Aft1. Corroborating our hypothesis we found that ace1 cells 
exposed to a prolonged copper treatment (15 hours) exhibit higher intracellular copper 
and iron levels compared to WT, as measured by ICP-AES. (Figure 3.4 B and C). As 
expected, copper and iron contents in the ace1 strain were dependent on Aft1, suggesting 
a role of Ace1 in preventing Aft1 activation. 
 Overall these results suggest that Ace1 regulates FET3 gene to prevent Aft1 
hyper-activation.  
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Figure 3.4 - Ace1 prevents Aft1 hyper-activation under copper excess conditions. A: WT (wild-type) and 
ace1 strains were challenged with 2mM CuSO4 and harvested at the indicated time points. The expression 
of CTH2 was monitored by qRT-PCR. B:  Copper content of WT, aft1, ace1 and ace1aft1 strains, after 
treatment with 2mM CuSO4 (+Cu) for 15 was determined by ICP-AES. C: Fe content of WT, aft1, ace1 
and ace1aft1 strains were determined by ICP-AES, in SC medium or after treatment with 2mM CuSO4 
(+Cu) for 15 h. Significance of differences was calculated with the t-test (* p<0.05) 
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Remarkably, we found that copper alleviates the growth deficiency exhibited by the 
aft1 mutant under normal growth conditions (Figure 3.1A), being the effect more evident 
the higher was the concentration of copper tested (Figure 3.5A). As Ace1 regulates FET3 
in copper surplus (figure 3.3) and as iron supplementation also attenuates aft1 growth 
defect (Figure 3.5B), we first reasoned that copper could relieve the iron depletion sensed 
by the aft1 strain. To test this hypothesis, we measured by ICP-AES the intracellular 
levels of iron in WT and aft1 strains, after copper treatment. Contrary to our expectation, 
we observed that the iron content of the aft1 mutant was decreased by approximately 50% 
in the presence of copper (Figure 3.5C). As Aft1 regulates several genes of copper 
metabolism we also tested, whether aft1 cells could be copper deficient, before copper 
treatment. ICP-AES analyses of copper contents led us to rule out this possibility, as 
intracellular copper levels are similar in both strains (Figure 3.5D). 
Because differences in iron and copper levels between aft1 and WT strains could not 
explain the growth fitness of Aft1 after of copper supplementation, we decided to explore 
whether cellular processes dependent on copper were affected in the mutant aft1. Copper 
is an essential player in respiratory metabolism and oxidative stress regulation, as it is a 
cofactor for cytochrome C oxidase (CcO) and Cu,Zn-Superoxide dismutase (SOD1), 
respectively [28, 90]. Iron-depleted cells and aft1 mutants are hypersensitive to oxidative 
stress and defective in respiratory growth [91]. Accordingly, SOD1 is induced in high 
copper conditions by Ace1 [58] and copper supplementation increases growth fitness 
when cells are cultured in medium containing a non-fermentable carbon source [36, 92]. 
As such, we next tested if copper was rescuing aft1 growth defect by promoting the 
respiratory metabolism and/or strengthening the oxidative stress response.  
To examine the respiratory metabolism, the growth of WT and aft1 strains was 
inspected in medium containing almost exclusively non-fermentable carbon sources 
(YPDGE), which is commonly used to assess mitochondrial function [82]. We observed 
that aft1 is sensitive to growth in YPDGE, a finding which is consistent with the 
knowledge that aft1 strains are defective in mitochondrial function [91], and we found 
that copper supplementation to the medium rescues growth (Figure 3.5E).  
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Finally, as a first approach to understand whether the oxidative stress response could 
be enhanced in the aft1 strain upon copper addition, we monitored the growth of WT and 
aft1 strains in the presence of paraquat and copper, (Figure 3.5F). Paraquat is a redox-
cycling drug that produces superoxide anion [93]. We noticed that aft1 is sensitive to the 
drug, but the growth deficiency is significantly attenuated by copper (Figure 3.5F). 
  
Figure 3.5 - Copper rescues the growth defect exhibited by the aft1 strain. A: Exponentially growing WT 
and aft1 were serially diluted and spotted onto SC plates and SC plates supplemented with 2, 3 or 5 mM 
CuSO4. Growth was recorded at 48hours incubation at 30ºC. B: Exponentially growing WT and aft1 were 
serially diluted and spotted onto SC plates and SC plates supplemented with 500µM FeSO4. Growth was 
recorded at 48hours incubation at 30ºC. C: Fe content of WT and aft1 strains were determined by ICP-
AES, in SC medium or after treatment with 2mM CuSO4 (+Cu) for 15 h. D: Copper content of WT and 
aft1 strains were determined by ICP-AES, in SC medium. E: Growth sensitivity of WT and aft1 in YPD 
and YPDGE plates containing 2mM CuSO4 .(+Cu) F: Growth sensitivity of WT and aft1 in YPD containing 
500 µM of Paraquat, supplemented with 2mM CuSO4 (+Cu). Significance of differences was calculated 
with the t-test (* p<0.05). 
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In Saccharomyces cerevisiae, the response to copper overload is regulated by 
Ace1, a copper-responsive transcription factor that activates Cu-detoxification genes, 
such as CUP1 and CRS5, which encode proteins involved in the sequestration of free 
copper ions but also SOD1 that mediates the detoxification of reactive oxygen species 
generated by Cu-driven Fenton reactions and acts as a cytosolic buffer of free copper ions 
[31, 32, 58]. In this study another role of Ace1 in copper detoxification was unveiled.  
The data here presented clearly shows that in conditions of copper overload, Ace1 
is the major regulator of FET3 gene. Indeed both protein and transcript levels of Fet3 are 
decreased in the mutant ace1 (Figure 3.3). Other authors had already reported that copper 
induced the expression of FET3, yet the mechanism underlying this regulation remained 
unclear [63, 75]. Interestingly, the idea that Ace1 might play a role in FET3 regulation 
was addressed by Gross et al. [63]. The authors demonstrated that ace1 cells failed to 
display copper-induced expression of FET3. They also showed that a reporter construct 
containing two putative Ace1-binding sites found in FET3 promoter was not able to drive 
the expression of the reporter gene These findings, together with de dependence of FET3 
on Aft1, led them to conclude that a possible transient cooper-induced decrease in cellular 
iron pools would activate Aft1 and, consequently, FET3 expression. However, since the 
putative Ace1 sites were not shown, we cannot exclude the possibility that the chosen 
sequences were not relevant for Ace1 mediated gene activation, which would explain the 
discrepancy between our results and those of Gross et al. Moreover, in this work, two 
lines of evidence suggest that the dependence of FET3 on Ace1 is not mediated by Aft1. 
First, the fet3 mutant is more sensitive than the aft1 mutant (Figure 3.1). Second, FET3 
expression is induced in the aft1 mutant in an Ace1-dependent manner (Figure 3.3 D). 
Several authors had reported that Fet3 is important for Cu-detoxification and that 
its deletion leads to copper accumulation, which results is toxicity and cell death [76, 77]. 
Here we demonstrate that the hyper accumulation of copper in the fet3 mutant is fully 
dependent on Aft1 (Figure 3.2 A). We propose that Aft1 activation in such conditions is 
triggered by the iron-deficiency status of fet3 cells (Figure 3.2B). In such conditions, Aft1 
would induce the expression of low-affinity iron transporters that would massively 
transport copper, given its abundance in the extracellular milieu. We show that at least 
three Aft1 targets (FET4, ARN4 and FRE1) may be involved in this process, suggesting 
that the excessive uptake of copper observed in fet3 mutant is probably the consequence 
of the upregulation of several low-affinity membrane transporters (e.g. FET4) and/or 
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genes involved in iron uptake (e.g. ARN4 and FRE1), rather than the action of a single 
protein.  
The finding that Aft1 activity could be deleterious to cells under copper excess, 
led us to put forward the hypothesis that Ace1 regulation of FET3 gene is serving the 
purpose of avoiding Aft1 activation. If copper induces a transient decrease of intracellular 
iron pools, the activation of FET3 via Ace1 would re-establish iron homeostasis without 
the need of Aft1 activation. According to this hypothesis, after copper addition, we 
observed a drastic increase in the expression of Aft1 target gene CTH2 in the ace1 mutant 
(Figure 3.4 A), suggesting that ace1 mutants cells experience iron depletion and 
consequently hyper-activate Aft1 (Figure 3.4A). Accordingly, copper and iron 
accumulation observed in the ace1 mutant, after prolonged treatment with copper (15 
hours), is dependent of Aft1 (Figure 3.4 B and C, ace1 strain vs. aft1ace1 strain). 
Interestingly, we found that the double mutant aft1fet3 is more sensitive to copper 
(Figure 3.1) than fet3 and aft1 single mutants, although it has a lower copper content as 
compared to fet3 (Figure 3.2 A). These data suggest that Fet3 role in copper toxicity goes 
beyond the avoidance of copper uptake by low-affinity iron transporters. In line with these 
results, the Thiele group proposed that Fet3, being a copper-protein, also detoxifies 
copper by scavenging copper ions  [75]. 
Finally in this work we also report that copper increases aft1 mutant fitness 
(Figure 3.5 A). Iron-deprived cells are defective in growing in non-fermentable carbon 
sources, such as glycerol, since the metabolic response to iron-deprivation leads to the 
downregulation of iron-consuming pathways, one of which is oxidative phosphorylation 
[91, 94, 95]. Accordingly, our data indicate that in the aft1 mutant the respiratory 
metabolism is affected and that copper, in an as yet unidentified way, compensates this 
deficiency (Figure 3.5 E). Similar results were reported by Blaiseau et al., who found that 
the sensitivity of the aft1 mutant to raffinose was rescued by copper addition [91]. In 
addition we also found that the aft1 mutant is sensitive to paraquat, a superoxide anion 
producer drug, and that copper slightly alleviates this growth phenotype (Figure 3.5 F) 
[93] . One plausible explanation for this finding is that activation of SOD1 gene by Ace1 
[58] contributes to superoxide anion detoxification. Both, deficient respiratory 
metabolism and/or deficient detoxification of superoxide anion, may account for aft1 
mutant growth failure under normal growth conditions. 
36 
 
 
 
37 
 
Ace1 is the transcription factor that in the yeast Saccharomyces cerevisiae orchestrates 
copper detoxification. In this work we have identified a novel target of Ace1 unveiling a 
novel line of protection mediated by Ace1 against copper toxicity.  
Overall, our findings suggest that under copper overload conditions: 
 
1. Aft1 is not the major regulator of FET3 gene expression. 
2. Aft1 mediates copper accumulation observed in the fet3 mutant. 
3. Ace1 regulates FET3 gene. 
4. Aft1 is hyper activated in the absence of Ace1. 
 
In light of the data described herein, we proposed that under copper-overload, 
Ace1 is activated leading to the upregulation of FET3 gene. Induction of FET3 gene 
serves a dual purpose: on the one hand, as Fet3 is a copper-containing protein, it 
contributes to diminish the pool of free copper ions; on the other hand it prevents cells 
from sensing iron depletion, thereby avoiding the hyper-activation of Aft1 and preventing 
further accumulation of copper ions (Figure 5.1).  
In a near future it would be interesting to: 
- Perform Chromatin Immunoprecipitation (ChIP), to elucidate if the Ace1 site 
found in FET3 promoter is functional.  
- Measure by qRT-PCR the dependence of FET3 expression on Aft1 under 
copper surplus. 
- Generate the triple mutant fet3fet4arn4, the quadruple mutant fet3fet4arn4fre1 
and measure intracellular copper levels in these mutants and in the double 
mutants described in this work, in order to give further insights into the 
contribution of each protein to copper-accumulation. 
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- Construct the double mutant aft1sod1 and assayed its growth in medium 
supplemented with copper, to evaluate if activation of SOD1 is on the basis of 
aft1 fitness induced by copper  
Figure 5.1 - Model for the role of Ace1 in copper detoxification. Under copper (Cu) overload conditions, Ace1, 
the transcription factor involved in the detoxification of copper, activates the expression of copper detoxification 
genes such as SOD1, CUP1 and CRS5. In this study, we have showed that Ace1 regulates FET3, a multicopper 
oxidase essential for Fe uptake. This regulation serves as to restrict Aft1 hyper-activation, whose target 
expression, can lead to cell death. The novel pathway for Ace1-mediated copper detoxification proposed in this 
study is depicted in red. 
 
 
39 
 
 
 
 
 
 
 
 
 
 
40 
 
Table S3 - List of oligonucleotides (primers) used in this study. Highlighted in bold are the sequences complementary 
to the histidine marker (HIS) or kanamycin (KAN). 
Primer Sequence Use 
A1_AFT1 5’CTCATGAAAACTGCGTCC 3’ 
Mutant 
confirmation 
A4_AFT1 5’GCGCCACTGAAAACACTA 3’ 
Mutant 
confirmation 
AFT1_KO_HIS_Fw 
5’ATGGAAGGCTTCAATCCGGCTGACATAGAACATGCGTCAA
TCGTACGCTGCAGGTC 3’ 
Deletion 
mutant 
AFT1_KO_HIS_Rv 
5’CTAATCTTCTGGCTTCACATACTTCAACTCGCCGTTCACTT
AGGGAGACCGGCAGAT 3’ 
Deletion 
mutant 
A1_ACE1 5’ATCTAGGGATGAGCTGAACG 3’ 
Mutant 
confirmation 
A4_ACE1 5’GAACAAACAACCGCCAATAT 3’ 
Mutant 
confirmation 
ACE1_KO_Kan_Fw 
5’GATGTAATTTATTAGACGGCGGCTTGATAAAAGAGGACTG
ATAATCAGTGTATTCACAGCGTACGCTGCAGGTCGAC 3’ 
Deletion 
mutant 
ACE1_KO_Kan_Rv 
5’CGGGAGAACAAACAACCGCCAATATATGTATATGTATATT
TATATAGATGTCCAGATGCAGCATAGGCCACTAGTGGATC
TG 3’ 
Deletion 
mutant 
A1_FRE1 5’AAAGTGCCTGATCTTGCGATG 3’ 
Mutant 
confirmation 
A4_FRE1 5’CTCTCTCAACAGGCAAAGGAAG 3’ 
Mutant 
confirmation 
FRE1_K7_HIS_Fw 
5’GTAATATAATCATCTAATTTCTCGCATATTCACGCCGACG
GAAGAACGAGCCGGATCAATATCGTACGCTGCAGG 3’ 
Deletion 
mutant 
FRE1_K7_HIS_Rv 
5’TTATCCGATAAAGCAACAAAATAACAAAAGTATGCGTGC
AAGAATTATTAACAAGGGGCCTTAGGGAGACCGGCAGAT 
3’ 
Deletion 
mutant 
A1_ARN4 5’ACGGCTTACAATTGCACCC 3’ 
Mutant 
confirmation 
A4_ARN4 5’CTACGGGAAATGACAGGTGCG 3’ 
Mutant 
confirmation 
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ARN4_K7_HIS_Fw 
5’GGTTTGGGTCCTAGCAGAACTCTAATATAGCAAAAAAGTG
CTCGTGAATGTCTCTCTGAAATCGTACGCTGCAGG 3’ 
Deletion 
mutant 
ARN4_K7_HIS_Rv 
5’AGAGAATTCTAGTTCAGGAAAGAGCTTAACACTATATTTG
TATCGCTAGTACTCTCCAGCTTAGGGAGACCGGCAGAT 3’ 
Deletion 
mutant 
A1_FET4 5’TGGCTCGAACAACGACAAAA 3’ 
Mutant 
confirmation 
A4_FET4 5’TCGGAATTCCACGTCAAGGT 3’ 
Mutant 
confirmation 
FET4_K7_HIS_Fw 
5’ATATAGAAACCTAATAAGACCCTTATTATTAAACATTCGT
TAATCAAATTATGGGTAAAAATCGTACGCTGCAGG 3’ 
Deletion 
mutant 
FET4_K7_HIS_Rv 
5’TTAACTCCCTCATAAGTAACATGAGGAATTCTTCCCACTA
ATGCTAAAATGTTCAATGAAGCTATTTTTCTTAGGGAGACC
GGCAGAT 3’ 
Deletion 
mutant 
qFET3_Fw 5’ACGGTGTGAATTACGCCTTC 3’ qRT-PCR 
qFET3_Rv 5’TTGGAAAGCGTGACCATGTA 3’ qRT-PCR 
qCTH2_Fw 5’ AGGTATGCTGCTGGAGCTGT 3’ qRT-PCR 
qCTH2_Rv 5’ GAGGGCCATGAAGGTATCAA 3’ qRT-PCR 
ACT1_Fw 5’CTATTGGTAACGAAAGATTCAG 3’ qRT-PCR 
ACT1_Fw 5’CCTTACGGACATCGACATCA 3’ qRT-PCR 
Fw_pFET3 5’GCTCTAGACAAAATTCAGCGCCTGCGT3’ pFET3-lacZ 
Rv_pFET3 5’GGGGTACCCGAGAAAAGCAAAACGGCT3’ pFET3-lacZ 
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